Search results for "clinical trial"

When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

Crohn’s disease remains one of the most challenging inflammatory bowel diseases to manage. Patients with refractory—or treatment-resistant—Crohn’s...
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological approach relied on aggressive...
AI Fills the Care Gap: VUNO’s DeepCARS Cuts In-Hospital Cardiac Arrests by 21% Without Rapid Response Teams

AI Fills the Care Gap: VUNO’s DeepCARS Cuts In-Hospital Cardiac Arrests by 21% Without Rapid Response Teams

Unlike intensive care units , general hospital wards do not feature continuous, around-the-clock patient monitoring.
SCL Healthcare Secures U.S. Patent for Genetic Test Predicting Metabolic Syndrome Risk

SCL Healthcare Secures U.S. Patent for Genetic Test Predicting Metabolic Syndrome Risk

SCL Healthcare has successfully secured a U.S. patent for a novel genetic testing technology designed to predict an...
Clue to Treating Fatty Liver May Reside in the Gut, Not the Liver, Study Suggests

Clue to Treating Fatty Liver May Reside in the Gut, Not the Liver, Study Suggests

Concern over liver health is steadily intensifying worldwide. Fatty liver disease occurs when lipid accumulation...
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood

Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood

Curocell, a South Korean clinical-stage biotech company specializing in chimeric antigen receptor T-cell (CAR-T)...
RNA Therapy Emerges as Critical Fast-Track for Cholesterol Control After Heart Attacks

RNA Therapy Emerges as Critical Fast-Track for Cholesterol Control After Heart Attacks

Myocardial infarction and unstable angina are life-threatening medical emergencies that occur when the blood vessels...
The Four-Minute Miracle: How a Tiny Daily Workout Protects Senior Independence

The Four-Minute Miracle: How a Tiny Daily Workout Protects Senior Independence

For many older adults, aging announces itself in small, restrictive ways. A trip to the local supermarket—even if it is...
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...
Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight

Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight

For decades, Alzheimer’s disease research has focused intensely on two primary culprits: beta-amyloid, which forms...